Cresco Labs Announces the Appointment of Sidney Dillard to Its Board of Directors

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced the appointment of Sidney Dillard to its board of directors, effective immediately. Ms. Dillard is an experienced financial services executive with over thirty years of experience providing advice and capital solutions to Fortune 500 corporations and middle market companies.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210521005063/en/

Financial Services Executive Sidney Dillard was appointed to the Board of Directors of Cresco Labs (Photo: Business Wire)

Financial Services Executive Sidney Dillard was appointed to the Board of Directors of Cresco Labs (Photo: Business Wire)

"I'm pleased to welcome Sidney to the Cresco Labs' board as our newest independent director. She has an outstanding track record of advising companies on raising and deploying capital. Her advice will be invaluable as we continue to prepare for a potential U.S. listing, deploy capital to go deeper in our strategic footprint, and optimize our capital structure," said Charlie Bachtell, Cresco Labs' CEO and co-founder.

Ms. Dillard currently serves as partner and head of corporate investment banking at Loop Capital Markets, one of the largest privately held investment banks in the U.S., where she has contributed to a significant increase in the firm's revenue over the last five years. Her clients have included companies in a wide range of industries, including consumer products, retail, and real estate, among others. In her current role, Sidney is responsible for setting and executing the firm's growth strategy and serves as lead advisor to her firm's corporate clients on their capital raising and advisory needs. She also serves on the firm's Management Committee, Risk Committee, and Fairness & Valuation Committee.

Over her career, Ms. Dillard has been responsible for raising over $600 billion across bond underwriting, initial public offerings, at-the-markets, share repurchases, private institutional capital raising and mergers & acquisitions advisory. Prior to Loop Capital Markets, she was Senior Vice President and Division Manager at The Northern Trust Bank, focusing on corporate client services and relationship development.

Ms. Dillard's philanthropic endeavors are focused on leadership, empowerment and access for women, girls, and African Americans. She is board chair for the Girl Scouts of Greater Chicago and Northwest Indiana and is a board member for the National Association of Securities Professionals, The Chicago Network, and IFF, which is a mission-driven lender (CDFI) and developer that helps people thrive by creating opportunities for low-income communities and people with disabilities. Sidney also serves on the Obama Foundation Inclusion Council. Ms. Dillard is a graduate of Stanford University and holds an MBA from Northwestern University's Kellogg School of Management.

"We are absolutely delighted that Sidney will be bringing both her financing expertise and her deep insights about inclusion and community to our board and our company, which will enable us to further expand our industry-leading role in social impact and the effect it has on generating shareholder value," said Tom Manning, Executive Chairman of the Board of Cresco Labs.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry's largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com .

Forward Looking Statements

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,' ‘will,' ‘should,' ‘could,' ‘would,' ‘expects,' ‘plans,' ‘anticipates,' ‘believes,' ‘estimates,' ‘projects,' ‘predicts,' ‘potential' or ‘continue' or the negative of those forms or other comparable terms. The Company's forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the Company's Annual Information Form for the year ended December 31, 2020 expected to be filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Jake Graves, Cresco Labs
Manager, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

News Provided by Business Wire via QuoteMedia

The Conversation (0)
Cannabis leaves.

Cannabis Market Update: H1 2024 in Review

The North American cannabis industry continued to demonstrate resilience in the first half of 2024, with recent data from market watchers showing a promising picture for the years ahead.

A Research and Markets report shows the North American market is seen experiencing significant growth, expanding from a size of US$35.6 billion in 2023 to a projected US$298.5 billion by 2032. This represents a substantial compound annual growth rate of 26.65 percent, indicating a remarkable increase in market value over the forecast period.

While the US and Canada still face challenges, the MJBiz Factbook says more than 48 percent of revenue-generating cannabis businesses expect the industry to perform “somewhat better” or “much better” in the next 12 months.

Keep reading...Show less

Trulieve Launches #YesOn3 Product Line to Support Adult Use Campaign in Florida

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the launch of a new specialty product line supporting the ballot initiative to legalize adult cannabis use in Florida .

#YesOn3 products will include pre-rolls, flower, gummies, and vape cartridges

The initial offerings will be available beginning Tuesday, July 30 , with the first in a series of product releases and specials leading up to Election Day on Tuesday, November 5 . Trulieve's proceeds from #YesOn3 specialty products may be used to support Amendment 3.

"We are proud to launch this new product line in support of #YesOn3 and Smart & Safe Florida ," said Trulieve's Chief Executive Officer Kim Rivers . " Florida adults deserve access to regulated and tested cannabis products, and the freedom to make their own choices about safe, responsible use."

All specialty products support Amendment 3 feature one of two new cannabis strains. The first strain, "Yo3" is a collaboration between Trulieve and Sunshine Cannabis. The second strain, named "Yon3" is a Trulieve-specific strain. #YesOn3 products will include pre-rolls, flower, gummies, and vape cartridges.

For information on how to register to vote in Florida , visit https://registertovoteflorida.gov/home . #YesOn3 yard signs will be available beginning on August 2 for patients to pickup at Florida retail locations while supplies last.

Across Florida , Trulieve offers home delivery, convenient online ordering, and in-store pickup. Veterans receive 20% off every order when they show their military ID, and all first-time guests are eligible for a 60% new customer discount at any Florida Trulieve location. For more information, or to learn how to become a registered patient, please visit Trulieve.com and connect on Instagram or Facebook .

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
X: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-launches-yeson3-product-line-to-support-adult-use-campaign-in-florida-302209307.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2024/30/c5367.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Ocala, Florida

New Marion County location will host grand opening celebration Friday, August 2nd

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Ocala, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 second quarter earnings conference call on Thursday, August 8, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders (the "Meeting") reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company's independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration.

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company's SEDAR+ profile at www.sedarplus.com and the Company's Form 8-K filed on EDGAR at www.sec.gov/edgar.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

U.S. Cannabis Market Soars Amid Legal Reforms, But Safety Concerns Persist

-

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×